Tower Research Capital LLC (TRC) - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 17 filers reported holding UNICYCIVE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$9,261
-12.6%
18,485
+140.8%
0.00%
Q1 2024$10,596
+80.6%
7,678
+13.6%
0.00%
Q4 2023$5,867
+122.4%
6,759
+120.3%
0.00%
Q3 2023$2,638
-0.3%
3,068
+48.4%
0.00%
Q2 2023$2,646
+37700.0%
2,067
-39.5%
0.00%
Q1 2023$7
+133.3%
3,419
-31.6%
0.00%
Q4 2022$3
-99.9%
4,996
-3.5%
0.00%
Q3 2022$3,000
-25.0%
5,177
+0.2%
0.00%
Q2 2022$4,000
-20.0%
5,167
+34.5%
0.00%
Q1 2022$5,0003,8410.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Rosalind Advisors, Inc. 1,571,200$787,3280.61%
Vivo Capital, LLC 3,470,152$1,738,8930.16%
Logos Global Management LP 3,469,927$1,738,7800.14%
Nantahala Capital Management 2,820,358$1,413,2820.08%
Monashee Investment Management LLC 1,000,000$501,1000.06%
BVF INC/IL 2,200,000$1,102,4200.03%
RA Capital Management 2,632,200$1,318,9950.02%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$7,0840.00%
Scientech Research LLC 10,969$5,4970.00%
Redwood Wealth Management Group, LLC 3,000$1,5030.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders